SMO South Africa

South Africa, with its long history of conducting clinical trials and a reputation for good study conduct during past decades, became an important destination for many international Sponsors looking to carry out clinical trials.

Understanding current needs of our clients, and the challenges in Temperature Sensitive distribution in this region, SMO Group has expanded its services to South African, opening a new State-of-the-Art depot at Pretoria.

The new facility operates in accordance with the highest international standards and offers a gateway to the rest of sub-Sahara Africa, providing the potential to conduct clinical trials in neighbouring countries including Botswana, Lesotho, Zimbabwe and Mozambique and also Kenya and Ghana to be utilized as distribution hubs to other African states.

Managing Director: Rob Van Den Bergh

Country information

South Africa, the southernmost country on the African continent, covers an area of approximately 1.21 million kms. The country is truly full of diversity – consists of 9 provinces, speaking 11 official languages.

Africa accounts for 24% of the global disease burden, while HIV/AIDS, tuberculosis and malaria remain a major problem. South Africa has one of the highest rates of HIV and AIDS infections in the world, more than 10% of the entire population.

With its population of more than 55 million people representing a huge ethnic variety, South Africa is ranked 20 out of 40 leading countries according to the number of sites vs population. The country also proves its competitiveness through high quality clinical trial performance.